BindingDB logo
myBDB logout

USPatent US9266832

Compile data set for download or QSAR
Found 90 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kJ/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
Alpha-synuclein


(Homo sapiens (Human))		BDBM207849
PNG
(US9266832, Cpd006)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cn4cccn4)c3)c2c1
Show InChI InChI=1S/C21H19ClN4O/c22-18-5-6-20-19(12-18)17(13-24-20)7-9-23-21(27)16-4-1-3-15(11-16)14-26-10-2-8-25-26/h1-6,8,10-13,24H,7,9,14H2,(H,23,27)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 256n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207852
PNG
(US9266832, Cpd009)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccccc3Cc3ccccc3)c2c1
Show InChI InChI=1S/C24H21ClN2O/c25-20-10-11-23-22(15-20)19(16-27-23)12-13-26-24(28)21-9-5-4-8-18(21)14-17-6-2-1-3-7-17/h1-11,15-16,27H,12-14H2,(H,26,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 240n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207861
PNG
(US9266832, Cpd018)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(CNCC4CCCCC4)cc3)c2c1
Show InChI InChI=1S/C25H30ClN3O/c26-22-10-11-24-23(14-22)21(17-29-24)12-13-28-25(30)20-8-6-19(7-9-20)16-27-15-18-4-2-1-3-5-18/h6-11,14,17-18,27,29H,1-5,12-13,15-16H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 168n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207862
PNG
(US9266832, Cpd019)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(CNCc4ccccc4)cc3)c2c1
Show InChI InChI=1S/C25H24ClN3O/c26-22-10-11-24-23(14-22)21(17-29-24)12-13-28-25(30)20-8-6-19(7-9-20)16-27-15-18-4-2-1-3-5-18/h1-11,14,17,27,29H,12-13,15-16H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 103n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207872
PNG
(US9266832, Cpd029)
Show SMILES COc1ccccc1Cc1ccc(cc1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12
Show InChI InChI=1S/C25H23ClN2O2/c1-30-24-5-3-2-4-19(24)14-17-6-8-18(9-7-17)25(29)27-13-12-20-16-28-23-11-10-21(26)15-22(20)23/h2-11,15-16,28H,12-14H2,1H3,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 84n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207884
PNG
(US9266832, Cpd041)
Show SMILES FC(F)(F)c1ccccc1Cc1ccc(cc1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12
Show InChI InChI=1S/C25H20ClF3N2O/c26-20-9-10-23-21(14-20)19(15-31-23)11-12-30-24(32)17-7-5-16(6-8-17)13-18-3-1-2-4-22(18)25(27,28)29/h1-10,14-15,31H,11-13H2,(H,30,32)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 80n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207887
PNG
(US9266832, Cpd044)
Show SMILES FC(F)(F)c1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C25H20ClF3N2O/c26-21-7-8-23-22(14-21)19(15-31-23)9-10-30-24(32)18-5-1-3-16(12-18)11-17-4-2-6-20(13-17)25(27,28)29/h1-8,12-15,31H,9-11H2,(H,30,32)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 55n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207896
PNG
(US9266832, Cpd053)
Show SMILES Fc1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C24H20ClFN2O/c25-20-7-8-23-22(14-20)19(15-28-23)9-10-27-24(29)18-5-1-3-16(12-18)11-17-4-2-6-21(26)13-17/h1-8,12-15,28H,9-11H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 17n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207902
PNG
(US9266832, Cpd059)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4ccccc4C#N)cc3)c2c1
Show InChI InChI=1S/C25H20ClN3O/c26-22-9-10-24-23(14-22)21(16-29-24)11-12-28-25(30)18-7-5-17(6-8-18)13-19-3-1-2-4-20(19)15-27/h1-10,14,16,29H,11-13H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 68n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207923
PNG
(US9266832, Cpd080)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4ccsc4)cc3)c2c1
Show InChI InChI=1S/C22H19ClN2OS/c23-19-5-6-21-20(12-19)18(13-25-21)7-9-24-22(26)17-3-1-15(2-4-17)11-16-8-10-27-14-16/h1-6,8,10,12-14,25H,7,9,11H2,(H,24,26)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 18n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207925
PNG
(US9266832, Cpd082)
Show SMILES Fc1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(F)cc23)c1
Show InChI InChI=1S/C24H20F2N2O/c25-20-6-2-4-17(13-20)11-16-3-1-5-18(12-16)24(29)27-10-9-19-15-28-23-8-7-21(26)14-22(19)23/h1-8,12-15,28H,9-11H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 112n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207929
PNG
(US9266832, Cpd086)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4ccncc4)cc3)c2c1
Show InChI InChI=1S/C23H20ClN3O/c24-20-5-6-22-21(14-20)19(15-27-22)9-12-26-23(28)18-3-1-16(2-4-18)13-17-7-10-25-11-8-17/h1-8,10-11,14-15,27H,9,12-13H2,(H,26,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 151n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207937
PNG
(US9266832, Cpd094)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Nc4ccccc4)c3)c2c1
Show InChI InChI=1S/C23H20ClN3O/c24-18-9-10-22-21(14-18)17(15-26-22)11-12-25-23(28)16-5-4-8-20(13-16)27-19-6-2-1-3-7-19/h1-10,13-15,26-27H,11-12H2,(H,25,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 161n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207959
PNG
(US9266832, Cpd116)
Show SMILES Fc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(cc23)N2CCOCC2)c1
Show InChI InChI=1S/C28H28FN3O2/c29-24-3-1-2-21(17-24)16-20-4-6-22(7-5-20)28(33)30-11-10-23-19-31-27-9-8-25(18-26(23)27)32-12-14-34-15-13-32/h1-9,17-19,31H,10-16H2,(H,30,33)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 166n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207853
PNG
(US9266832, Cpd010)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cc4ccccc4)c3)c2c1
Show InChI InChI=1S/C24H21ClN2O/c25-21-9-10-23-22(15-21)20(16-27-23)11-12-26-24(28)19-8-4-7-18(14-19)13-17-5-2-1-3-6-17/h1-10,14-16,27H,11-13H2,(H,26,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 78n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207858
PNG
(US9266832, Cpd015)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4ccccc4)cc3)c2c1
Show InChI InChI=1S/C24H21ClN2O/c25-21-10-11-23-22(15-21)20(16-27-23)12-13-26-24(28)19-8-6-18(7-9-19)14-17-4-2-1-3-5-17/h1-11,15-16,27H,12-14H2,(H,26,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 154n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207885
PNG
(US9266832, Cpd042)
Show SMILES FC(F)(F)c1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C25H20ClF3N2O/c26-21-8-9-23-22(14-21)19(15-31-23)10-11-30-24(32)18-6-4-16(5-7-18)12-17-2-1-3-20(13-17)25(27,28)29/h1-9,13-15,31H,10-12H2,(H,30,32)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 31n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207889
PNG
(US9266832, Cpd046)
Show SMILES Clc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C24H20Cl2N2O/c25-20-3-1-2-17(13-20)12-16-4-6-18(7-5-16)24(29)27-11-10-19-15-28-23-9-8-21(26)14-22(19)23/h1-9,13-15,28H,10-12H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 7n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207893
PNG
(US9266832, Cpd050)
Show SMILES Clc1ccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1
Show InChI InChI=1S/C24H20Cl2N2O/c25-20-6-4-16(5-7-20)12-17-2-1-3-18(13-17)24(29)27-11-10-19-15-28-23-9-8-21(26)14-22(19)23/h1-9,13-15,28H,10-12H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 50n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207895
PNG
(US9266832, Cpd052)
Show SMILES Fc1ccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1
Show InChI InChI=1S/C24H20ClFN2O/c25-20-6-9-23-22(14-20)19(15-28-23)10-11-27-24(29)18-3-1-2-17(13-18)12-16-4-7-21(26)8-5-16/h1-9,13-15,28H,10-12H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 20n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207910
PNG
(US9266832, Cpd067)
Show SMILES Fc1cc(F)cc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C24H19ClF2N2O/c25-19-5-6-23-22(12-19)18(14-29-23)7-8-28-24(30)17-3-1-15(2-4-17)9-16-10-20(26)13-21(27)11-16/h1-6,10-14,29H,7-9H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 111n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207918
PNG
(US9266832, Cpd075)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cc4cccs4)c3)c2c1
Show InChI InChI=1S/C22H19ClN2OS/c23-18-6-7-21-20(13-18)17(14-25-21)8-9-24-22(26)16-4-1-3-15(11-16)12-19-5-2-10-27-19/h1-7,10-11,13-14,25H,8-9,12H2,(H,24,26)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 30n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207936
PNG
(US9266832, Cpd093)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Oc4ccccc4)cc3)c2c1
Show InChI InChI=1S/C23H19ClN2O2/c24-18-8-11-22-21(14-18)17(15-26-22)12-13-25-23(27)16-6-9-20(10-7-16)28-19-4-2-1-3-5-19/h1-11,14-15,26H,12-13H2,(H,25,27)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 293n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207875
PNG
(US9266832, Cpd032)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4cccc(c4)C#N)cc3)c2c1
Show InChI InChI=1S/C25H20ClN3O/c26-22-8-9-24-23(14-22)21(16-29-24)10-11-28-25(30)20-6-4-17(5-7-20)12-18-2-1-3-19(13-18)15-27/h1-9,13-14,16,29H,10-12H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 14n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207881
PNG
(US9266832, Cpd038)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cc4cccc(c4)C#N)c3)c2c1
Show InChI InChI=1S/C25H20ClN3O/c26-22-7-8-24-23(14-22)21(16-29-24)9-10-28-25(30)20-6-2-4-18(13-20)11-17-3-1-5-19(12-17)15-27/h1-8,12-14,16,29H,9-11H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 31n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207882
PNG
(US9266832, Cpd039)
Show SMILES FC(F)(F)c1ccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1
Show InChI InChI=1S/C25H20ClF3N2O/c26-21-9-10-23-22(14-21)19(15-31-23)11-12-30-24(32)18-5-1-16(2-6-18)13-17-3-7-20(8-4-17)25(27,28)29/h1-10,14-15,31H,11-13H2,(H,30,32)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 22n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207897
PNG
(US9266832, Cpd054)
Show SMILES Fc1ccccc1Cc1cccc(c1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12
Show InChI InChI=1S/C24H20ClFN2O/c25-20-8-9-23-21(14-20)19(15-28-23)10-11-27-24(29)18-6-3-4-16(13-18)12-17-5-1-2-7-22(17)26/h1-9,13-15,28H,10-12H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 42n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207900
PNG
(US9266832, Cpd057)
Show SMILES COc1ccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1
Show InChI InChI=1S/C25H23ClN2O2/c1-30-22-8-5-17(6-9-22)13-18-3-2-4-19(14-18)25(29)27-12-11-20-16-28-24-10-7-21(26)15-23(20)24/h2-10,14-16,28H,11-13H2,1H3,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 147n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207903
PNG
(US9266832, Cpd060)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cc4ccccc4C#N)c3)c2c1
Show InChI InChI=1S/C25H20ClN3O/c26-22-8-9-24-23(14-22)21(16-29-24)10-11-28-25(30)19-7-3-4-17(13-19)12-18-5-1-2-6-20(18)15-27/h1-9,13-14,16,29H,10-12H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 116n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207907
PNG
(US9266832, Cpd064)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Nc4cccc(c4)C#N)c3)c2c1
Show InChI InChI=1S/C24H19ClN4O/c25-19-7-8-23-22(13-19)18(15-28-23)9-10-27-24(30)17-4-2-6-21(12-17)29-20-5-1-3-16(11-20)14-26/h1-8,11-13,15,28-29H,9-10H2,(H,27,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 122n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207911
PNG
(US9266832, Cpd068)
Show SMILES COc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1F
Show InChI InChI=1S/C25H22ClFN2O2/c1-31-23-4-2-3-18(24(23)27)13-16-5-7-17(8-6-16)25(30)28-12-11-19-15-29-22-10-9-20(26)14-21(19)22/h2-10,14-15,29H,11-13H2,1H3,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 148n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207912
PNG
(US9266832, Cpd069)
Show SMILES Fc1cncc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C23H19ClFN3O/c24-19-4-5-22-21(11-19)18(13-28-22)6-7-27-23(29)17-3-1-2-15(9-17)8-16-10-20(25)14-26-12-16/h1-5,9-14,28H,6-8H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 90n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207916
PNG
(US9266832, Cpd073)
Show SMILES Fc1cc(F)cc(Cc2ccc(cc2)C(=O)NCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C23H17ClF2N2O/c24-18-5-6-22-21(10-18)17(12-27-22)13-28-23(29)16-3-1-14(2-4-16)7-15-8-19(25)11-20(26)9-15/h1-6,8-12,27H,7,13H2,(H,28,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 242n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207919
PNG
(US9266832, Cpd076)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cc4ccsc4)c3)c2c1
Show InChI InChI=1S/C22H19ClN2OS/c23-19-4-5-21-20(12-19)18(13-25-21)6-8-24-22(26)17-3-1-2-15(11-17)10-16-7-9-27-14-16/h1-5,7,9,11-14,25H,6,8,10H2,(H,24,26)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 29n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207922
PNG
(US9266832, Cpd079)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4cccs4)cc3)c2c1
Show InChI InChI=1S/C22H19ClN2OS/c23-18-7-8-21-20(13-18)17(14-25-21)9-10-24-22(26)16-5-3-15(4-6-16)12-19-2-1-11-27-19/h1-8,11,13-14,25H,9-10,12H2,(H,24,26)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 81n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207891
PNG
(US9266832, Cpd048 | US9266832, Cpd084)
Show SMILES Fc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C24H20ClFN2O/c25-20-8-9-23-22(14-20)19(15-28-23)10-11-27-24(29)18-6-4-16(5-7-18)12-17-2-1-3-21(26)13-17/h1-9,13-15,28H,10-12H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 26n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207935
PNG
(US9266832, Cpd092)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Nc4ccccc4)cc3)c2c1
Show InChI InChI=1S/C23H20ClN3O/c24-18-8-11-22-21(14-18)17(15-26-22)12-13-25-23(28)16-6-9-20(10-7-16)27-19-4-2-1-3-5-19/h1-11,14-15,26-27H,12-13H2,(H,25,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 76n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207943
PNG
(US9266832, Cpd100)
Show SMILES Fc1cccc(Cc2ccc(cc2F)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C24H19ClF2N2O/c25-19-6-7-23-21(13-19)18(14-29-23)8-9-28-24(30)17-5-4-16(22(27)12-17)10-15-2-1-3-20(26)11-15/h1-7,11-14,29H,8-10H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 44n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207947
PNG
(US9266832, Cpd104)
Show SMILES CN(c1ccc(cc1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12)c1cccc(F)c1
Show InChI InChI=1S/C24H21ClFN3O/c1-29(21-4-2-3-19(26)14-21)20-8-5-16(6-9-20)24(30)27-12-11-17-15-28-23-10-7-18(25)13-22(17)23/h2-10,13-15,28H,11-12H2,1H3,(H,27,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 264n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207854
PNG
(US9266832, Cpd011)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cn4cccn4)cc3)c2c1
Show InChI InChI=1S/C21H19ClN4O/c22-18-6-7-20-19(12-18)17(13-24-20)8-10-23-21(27)16-4-2-15(3-5-16)14-26-11-1-9-25-26/h1-7,9,11-13,24H,8,10,14H2,(H,23,27)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 173n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207855
PNG
(US9266832, Cpd012)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cn4ccnc4)cc3)c2c1
Show InChI InChI=1S/C21H19ClN4O/c22-18-5-6-20-19(11-18)17(12-25-20)7-8-24-21(27)16-3-1-15(2-4-16)13-26-10-9-23-14-26/h1-6,9-12,14,25H,7-8,13H2,(H,24,27)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 486n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207865
PNG
(US9266832, Cpd022)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(CNCc4cccs4)c3)c2c1
Show InChI InChI=1S/C23H22ClN3OS/c24-19-6-7-22-21(12-19)18(14-27-22)8-9-26-23(28)17-4-1-3-16(11-17)13-25-15-20-5-2-10-29-20/h1-7,10-12,14,25,27H,8-9,13,15H2,(H,26,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 159n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207871
PNG
(US9266832, Cpd028)
Show SMILES Cc1ccccc1Cc1ccc(cc1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12
Show InChI InChI=1S/C25H23ClN2O/c1-17-4-2-3-5-20(17)14-18-6-8-19(9-7-18)25(29)27-13-12-21-16-28-24-11-10-22(26)15-23(21)24/h2-11,15-16,28H,12-14H2,1H3,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 370n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207874
PNG
(US9266832, Cpd031)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4ccc(cc4)C#N)cc3)c2c1
Show InChI InChI=1S/C25H20ClN3O/c26-22-9-10-24-23(14-22)21(16-29-24)11-12-28-25(30)20-7-5-18(6-8-20)13-17-1-3-19(15-27)4-2-17/h1-10,14,16,29H,11-13H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 16n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207876
PNG
(US9266832, Cpd033)
Show SMILES Cc1ccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1
Show InChI InChI=1S/C25H23ClN2O/c1-17-2-4-18(5-3-17)14-19-6-8-20(9-7-19)25(29)27-13-12-21-16-28-24-11-10-22(26)15-23(21)24/h2-11,15-16,28H,12-14H2,1H3,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 31n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207901
PNG
(US9266832, Cpd058)
Show SMILES COc1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C25H23ClN2O2/c1-30-22-7-3-5-18(14-22)12-17-4-2-6-19(13-17)25(29)27-11-10-20-16-28-24-9-8-21(26)15-23(20)24/h2-9,13-16,28H,10-12H2,1H3,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 125n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207909
PNG
(US9266832, Cpd066)
Show SMILES COc1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1F
Show InChI InChI=1S/C25H22ClFN2O2/c1-31-23-7-3-5-17(24(23)27)12-16-4-2-6-18(13-16)25(30)28-11-10-19-15-29-22-9-8-20(26)14-21(19)22/h2-9,13-15,29H,10-12H2,1H3,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 386n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207938
PNG
(US9266832, Cpd095)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Oc4ccccc4)c3)c2c1
Show InChI InChI=1S/C23H19ClN2O2/c24-18-9-10-22-21(14-18)17(15-26-22)11-12-25-23(27)16-5-4-8-20(13-16)28-19-6-2-1-3-7-19/h1-10,13-15,26H,11-12H2,(H,25,27)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 241n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207939
PNG
(US9266832, Cpd096)
Show SMILES CN(c1ccccc1)c1ccc(cc1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12
Show InChI InChI=1S/C24H22ClN3O/c1-28(20-5-3-2-4-6-20)21-10-7-17(8-11-21)24(29)26-14-13-18-16-27-23-12-9-19(25)15-22(18)23/h2-12,15-16,27H,13-14H2,1H3,(H,26,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 470n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207942
PNG
(US9266832, Cpd099)
Show SMILES Fc1cccc(Cc2ccc(C(=O)NCCc3c[nH]c4ccc(Cl)cc34)c(F)c2)c1
Show InChI InChI=1S/C24H19ClF2N2O/c25-18-5-7-23-21(13-18)17(14-29-23)8-9-28-24(30)20-6-4-16(12-22(20)27)10-15-2-1-3-19(26)11-15/h1-7,11-14,29H,8-10H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 27n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207948
PNG
(US9266832, Cpd105)
Show SMILES Fc1cccc(Oc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C23H18ClFN2O2/c24-17-6-9-22-21(12-17)16(14-27-22)10-11-26-23(28)15-4-7-19(8-5-15)29-20-3-1-2-18(25)13-20/h1-9,12-14,27H,10-11H2,(H,26,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 112n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207949
PNG
(US9266832, Cpd106)
Show SMILES Fc1cccc(Nc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C23H19ClFN3O/c24-17-6-9-22-21(12-17)16(14-27-22)10-11-26-23(29)15-4-7-19(8-5-15)28-20-3-1-2-18(25)13-20/h1-9,12-14,27-28H,10-11H2,(H,26,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 82n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207954
PNG
(US9266832, Cpd111)
Show SMILES Fc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(cc23)-c2ccccc2)c1
Show InChI InChI=1S/C30H25FN2O/c31-27-8-4-5-22(18-27)17-21-9-11-24(12-10-21)30(34)32-16-15-26-20-33-29-14-13-25(19-28(26)29)23-6-2-1-3-7-23/h1-14,18-20,33H,15-17H2,(H,32,34)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 537n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207873
PNG
(US9266832, Cpd030)
Show SMILES COc1ccccc1Cc1cccc(c1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12
Show InChI InChI=1S/C25H23ClN2O2/c1-30-24-8-3-2-6-18(24)13-17-5-4-7-19(14-17)25(29)27-12-11-20-16-28-23-10-9-21(26)15-22(20)23/h2-10,14-16,28H,11-13H2,1H3,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 96n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207891
PNG
(US9266832, Cpd048 | US9266832, Cpd084)
Show SMILES Fc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C24H20ClFN2O/c25-20-8-9-23-22(14-20)19(15-28-23)10-11-27-24(29)18-6-4-16(5-7-18)12-17-2-1-3-21(26)13-17/h1-9,13-15,28H,10-12H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 13n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207898
PNG
(US9266832, Cpd055)
Show SMILES Clc1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C24H20Cl2N2O/c25-20-6-2-4-17(13-20)11-16-3-1-5-18(12-16)24(29)27-10-9-19-15-28-23-8-7-21(26)14-22(19)23/h1-8,12-15,28H,9-11H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 36n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207940
PNG
(US9266832, Cpd097)
Show SMILES CN(c1ccccc1)c1cccc(c1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12
Show InChI InChI=1S/C24H22ClN3O/c1-28(20-7-3-2-4-8-20)21-9-5-6-17(14-21)24(29)26-13-12-18-16-27-23-11-10-19(25)15-22(18)23/h2-11,14-16,27H,12-13H2,1H3,(H,26,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 270n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207946
PNG
(US9266832, Cpd103)
Show SMILES Fc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1F
Show InChI InChI=1S/C24H19ClF2N2O/c25-19-8-9-22-20(13-19)18(14-29-22)10-11-28-24(30)16-6-4-15(5-7-16)12-17-2-1-3-21(26)23(17)27/h1-9,13-14,29H,10-12H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 139n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207960
PNG
(US9266832, Cpd117)
Show SMILES Fc1cccc(Cc2cccc(n2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C23H19ClFN3O/c24-17-7-8-21-20(13-17)16(14-27-21)9-10-26-23(29)22-6-2-5-19(28-22)12-15-3-1-4-18(25)11-15/h1-8,11,13-14,27H,9-10,12H2,(H,26,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 109n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207866
PNG
(US9266832, Cpd023)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(CNCc4ccccc4)c3)c2c1
Show InChI InChI=1S/C25H24ClN3O/c26-22-9-10-24-23(14-22)21(17-29-24)11-12-28-25(30)20-8-4-7-19(13-20)16-27-15-18-5-2-1-3-6-18/h1-10,13-14,17,27,29H,11-12,15-16H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 94n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207867
PNG
(US9266832, Cpd024)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(CNC4CCCCC4)c3)c2c1
Show InChI InChI=1S/C24H28ClN3O/c25-20-9-10-23-22(14-20)19(16-28-23)11-12-26-24(29)18-6-4-5-17(13-18)15-27-21-7-2-1-3-8-21/h4-6,9-10,13-14,16,21,27-28H,1-3,7-8,11-12,15H2,(H,26,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 724n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207879
PNG
(US9266832, Cpd036)
Show SMILES Cc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C25H23ClN2O/c1-17-3-2-4-19(13-17)14-18-5-7-20(8-6-18)25(29)27-12-11-21-16-28-24-10-9-22(26)15-23(21)24/h2-10,13,15-16,28H,11-12,14H2,1H3,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 40n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207880
PNG
(US9266832, Cpd037)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cc4ccc(cc4)C#N)c3)c2c1
Show InChI InChI=1S/C25H20ClN3O/c26-22-8-9-24-23(14-22)21(16-29-24)10-11-28-25(30)20-3-1-2-19(13-20)12-17-4-6-18(15-27)7-5-17/h1-9,13-14,16,29H,10-12H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 32n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207888
PNG
(US9266832, Cpd045)
Show SMILES Clc1ccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1
Show InChI InChI=1S/C24H20Cl2N2O/c25-20-7-3-17(4-8-20)13-16-1-5-18(6-2-16)24(29)27-12-11-19-15-28-23-10-9-21(26)14-22(19)23/h1-10,14-15,28H,11-13H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 22n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207890
PNG
(US9266832, Cpd047)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4ccccc4Cl)cc3)c2c1
Show InChI InChI=1S/C24H20Cl2N2O/c25-20-9-10-23-21(14-20)19(15-28-23)11-12-27-24(29)17-7-5-16(6-8-17)13-18-3-1-2-4-22(18)26/h1-10,14-15,28H,11-13H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 65n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207915
PNG
(US9266832, Cpd072)
Show SMILES Clc1ccc2[nH]cc(CNC(=O)c3ccc(Cc4cccc(c4)C#N)cc3)c2c1
Show InChI InChI=1S/C24H18ClN3O/c25-21-8-9-23-22(12-21)20(14-27-23)15-28-24(29)19-6-4-16(5-7-19)10-17-2-1-3-18(11-17)13-26/h1-9,11-12,14,27H,10,15H2,(H,28,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 132n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207920
PNG
(US9266832, Cpd077)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cc4ccco4)c3)c2c1
Show InChI InChI=1S/C22H19ClN2O2/c23-18-6-7-21-20(13-18)17(14-25-21)8-9-24-22(26)16-4-1-3-15(11-16)12-19-5-2-10-27-19/h1-7,10-11,13-14,25H,8-9,12H2,(H,24,26)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 17n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207926
PNG
(US9266832, Cpd083)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cc4ccoc4)c3)c2c1
Show InChI InChI=1S/C22H19ClN2O2/c23-19-4-5-21-20(12-19)18(13-25-21)6-8-24-22(26)17-3-1-2-15(11-17)10-16-7-9-27-14-16/h1-5,7,9,11-14,25H,6,8,10H2,(H,24,26)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 56n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207930
PNG
(US9266832, Cpd087)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4ccco4)cc3)c2c1
Show InChI InChI=1S/C22H19ClN2O2/c23-18-7-8-21-20(13-18)17(14-25-21)9-10-24-22(26)16-5-3-15(4-6-16)12-19-2-1-11-27-19/h1-8,11,13-14,25H,9-10,12H2,(H,24,26)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 133n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207932
PNG
(US9266832, Cpd089)
Show SMILES COc1cccc(Oc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C24H21ClN2O3/c1-29-19-5-3-7-21(14-19)30-20-6-2-4-16(12-20)24(28)26-11-10-17-15-27-23-9-8-18(25)13-22(17)23/h2-9,12-15,27H,10-11H2,1H3,(H,26,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 98n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207934
PNG
(US9266832, Cpd091)
Show SMILES Cn1cc(CCNC(=O)c2ccc(Cc3cccc(F)c3)cc2)c2cc(Cl)ccc12
Show InChI InChI=1S/C25H22ClFN2O/c1-29-16-20(23-15-21(26)9-10-24(23)29)11-12-28-25(30)19-7-5-17(6-8-19)13-18-3-2-4-22(27)14-18/h2-10,14-16H,11-13H2,1H3,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 581n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207941
PNG
(US9266832, Cpd098)
Show SMILES Cc1[nH]c2ccc(Cl)cc2c1CCNC(=O)c1ccc(Cc2cccc(F)c2)cc1
Show InChI InChI=1S/C25H22ClFN2O/c1-16-22(23-15-20(26)9-10-24(23)29-16)11-12-28-25(30)19-7-5-17(6-8-19)13-18-3-2-4-21(27)14-18/h2-10,14-15,29H,11-13H2,1H3,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 535n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207945
PNG
(US9266832, Cpd102)
Show SMILES Fc1ccc(F)c(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C24H19ClF2N2O/c25-19-5-8-23-21(13-19)17(14-29-23)9-10-28-24(30)16-3-1-15(2-4-16)11-18-12-20(26)6-7-22(18)27/h1-8,12-14,29H,9-11H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 49n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207951
PNG
(US9266832, Cpd108)
Show SMILES Fc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(cc23)C(F)(F)F)c1
Show InChI InChI=1S/C25H20F4N2O/c26-21-3-1-2-17(13-21)12-16-4-6-18(7-5-16)24(32)30-11-10-19-15-31-23-9-8-20(14-22(19)23)25(27,28)29/h1-9,13-15,31H,10-12H2,(H,30,32)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 320n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207877
PNG
(US9266832, Cpd034)
Show SMILES Cc1ccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1
Show InChI InChI=1S/C25H23ClN2O/c1-17-5-7-18(8-6-17)13-19-3-2-4-20(14-19)25(29)27-12-11-21-16-28-24-10-9-22(26)15-23(21)24/h2-10,14-16,28H,11-13H2,1H3,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 62n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207883
PNG
(US9266832, Cpd040)
Show SMILES FC(F)(F)c1ccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1
Show InChI InChI=1S/C25H20ClF3N2O/c26-21-8-9-23-22(14-21)19(15-31-23)10-11-30-24(32)18-3-1-2-17(13-18)12-16-4-6-20(7-5-16)25(27,28)29/h1-9,13-15,31H,10-12H2,(H,30,32)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 103n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207899
PNG
(US9266832, Cpd056)
Show SMILES COc1ccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1
Show InChI InChI=1S/C25H23ClN2O2/c1-30-22-9-4-18(5-10-22)14-17-2-6-19(7-3-17)25(29)27-13-12-20-16-28-24-11-8-21(26)15-23(20)24/h2-11,15-16,28H,12-14H2,1H3,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 70n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207904
PNG
(US9266832, Cpd061)
Show SMILES Fc1ccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1
Show InChI InChI=1S/C24H20ClFN2O/c25-20-7-10-23-22(14-20)19(15-28-23)11-12-27-24(29)18-5-1-16(2-6-18)13-17-3-8-21(26)9-4-17/h1-10,14-15,28H,11-13H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 86n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207908
PNG
(US9266832, Cpd065)
Show SMILES Fc1cc(F)cc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C24H19ClF2N2O/c25-19-4-5-23-22(12-19)18(14-29-23)6-7-28-24(30)17-3-1-2-15(9-17)8-16-10-20(26)13-21(27)11-16/h1-5,9-14,29H,6-8H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 174n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207914
PNG
(US9266832, Cpd071)
Show SMILES Fc1cccc(Cc2ccc(cc2)C(=O)NCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C23H18ClFN2O/c24-19-8-9-22-21(12-19)18(13-26-22)14-27-23(28)17-6-4-15(5-7-17)10-16-2-1-3-20(25)11-16/h1-9,11-13,26H,10,14H2,(H,27,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 277n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207924
PNG
(US9266832, Cpd081)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4ccoc4)cc3)c2c1
Show InChI InChI=1S/C22H19ClN2O2/c23-19-5-6-21-20(12-19)18(13-25-21)7-9-24-22(26)17-3-1-15(2-4-17)11-16-8-10-27-14-16/h1-6,8,10,12-14,25H,7,9,11H2,(H,24,26)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 23n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207928
PNG
(US9266832, Cpd085)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4cccnc4)cc3)c2c1
Show InChI InChI=1S/C23H20ClN3O/c24-20-7-8-22-21(13-20)19(15-27-22)9-11-26-23(28)18-5-3-16(4-6-18)12-17-2-1-10-25-14-17/h1-8,10,13-15,27H,9,11-12H2,(H,26,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 117n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207950
PNG
(US9266832, Cpd107)
Show SMILES Fc1cccc(Cc2ccc(nc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C23H19ClFN3O/c24-18-5-7-21-20(12-18)17(14-28-21)8-9-26-23(29)22-6-4-16(13-27-22)10-15-2-1-3-19(25)11-15/h1-7,11-14,28H,8-10H2,(H,26,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 26n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207958
PNG
(US9266832, Cpd115)
Show SMILES Fc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(cc23)C#N)c1
Show InChI InChI=1S/C25H20FN3O/c26-22-3-1-2-18(13-22)12-17-4-7-20(8-5-17)25(30)28-11-10-21-16-29-24-9-6-19(15-27)14-23(21)24/h1-9,13-14,16,29H,10-12H2,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 75n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207869
PNG
(US9266832, Cpd026)
Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(CNCc4cccs4)cc3)c2c1
Show InChI InChI=1S/C23H22ClN3OS/c24-19-7-8-22-21(12-19)18(14-27-22)9-10-26-23(28)17-5-3-16(4-6-17)13-25-15-20-2-1-11-29-20/h1-8,11-12,14,25,27H,9-10,13,15H2,(H,26,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 83n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207878
PNG
(US9266832, Cpd035)
Show SMILES Cc1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C25H23ClN2O/c1-17-4-2-5-18(12-17)13-19-6-3-7-20(14-19)25(29)27-11-10-21-16-28-24-9-8-22(26)15-23(21)24/h2-9,12,14-16,28H,10-11,13H2,1H3,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 60n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207892
PNG
(US9266832, Cpd049)
Show SMILES Fc1ccccc1Cc1ccc(cc1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12
Show InChI InChI=1S/C24H20ClFN2O/c25-20-9-10-23-21(14-20)19(15-28-23)11-12-27-24(29)17-7-5-16(6-8-17)13-18-3-1-2-4-22(18)26/h1-10,14-15,28H,11-13H2,(H,27,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 31n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207905
PNG
(US9266832, Cpd062)
Show SMILES Cc1cccc(C)c1Cc1ccc(cc1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12
Show InChI InChI=1S/C26H25ClN2O/c1-17-4-3-5-18(2)23(17)14-19-6-8-20(9-7-19)26(30)28-13-12-21-16-29-25-11-10-22(27)15-24(21)25/h3-11,15-16,29H,12-14H2,1-2H3,(H,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 398n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207933
PNG
(US9266832, Cpd090)
Show SMILES Cc1cccc(Oc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1
Show InChI InChI=1S/C24H21ClN2O2/c1-16-4-2-6-20(12-16)29-21-7-3-5-17(13-21)24(28)26-11-10-18-15-27-23-9-8-19(25)14-22(18)23/h2-9,12-15,27H,10-11H2,1H3,(H,26,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 91n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
Alpha-synuclein


(Homo sapiens (Human))		BDBM207944
PNG
(US9266832, Cpd101)
Show SMILES Fc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ncc(Cl)cc23)c1
Show InChI InChI=1S/C23H19ClFN3O/c24-19-12-21-18(13-27-22(21)28-14-19)8-9-26-23(29)17-6-4-15(5-7-17)10-16-2-1-3-20(25)11-16/h1-7,11-14H,8-10H2,(H,26,29)(H,27,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1.05E+3n/an/an/an/a



Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent


Assay Description
α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...

US Patent US9266832 (2016)


BindingDB Entry DOI: 10.7270/Q2319TP6
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%